ExploreWatchlistsPricing
  1. JP-listed companies
  2. ONO PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Cost of revenue

ONO PHARMACEUTICAL CO., LTD. (4528)

Market cap
¥1.2T
P/E ratio
16.9x
Japanese pharmaceutical company that develops, manufactures and sells prescription and over-the-counter drugs through a global network of 26 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 2025147,950+16.38%
Mar 31, 2024127,126+15.50%
Mar 31, 2023110,062+17.70%
Mar 31, 202293,511+9.28%
Mar 31, 202185,573+8.23%
Mar 31, 202079,063-5.69%
Mar 31, 201983,829+34.49%
Mar 31, 201862,331-2.06%
Mar 31, 201763,639+53.31%
Mar 31, 201641,510+16.68%
Mar 31, 201535,576

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat